MedPath

Prospective clinical study to evaluate the clinical performance of immediately placed Astra DS Prime Taper implants:A monocenter study

Recruiting
Conditions
K08.1
Loss of teeth due to accident, extraction or local periodontal disease
Registration Number
DRKS00025234
Lead Sponsor
Goethe Universität Frankfurt, Zentrum der Zahn-, Mund- und Kieferheilkunde (Carolinum), Zahnärztliches Universitäts-Institut gGmbH, Poliklinik für Zahnärztliche Chirurgie und Implantologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
25
Inclusion Criteria

Males and females with an age of 18 to 69 years
- Planned single tooth replacement in maxilla (15-25 FDI) allowing the placement of a single implant
- Subject shall have a stable occlusal relationship
- Patient has been informed of the follow-up visits and is willing to return to the clinical center for these follow-up visits
- Subjects must have voluntarily signed the informed consent form before any study related action

Exclusion Criteria

- Systemic disease that would interfere with dental implant therapy (e.g. uncontrolled diabetes, osteoporosis)
- Bone metabolism disorders or medication (steroids, bisphosphonate)
-Pregnant or breastfeeding women

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Health of periimplant tissue measured as:<br>- Bleeding on probing (BOP)<br>- Mucosal recession (MR)<br>- probing depth (PD)<br>- Clinical attachment level (CAL))<br>- Volume changes of the periimplant soft tissue<br><br>Follow-up times: final prosthetic restoration, 6, 12 and 24 months after the final prosthetic restoration.
Secondary Outcome Measures
NameTimeMethod
impact of the treatment protocol on the periimplant soft and hart tissue
© Copyright 2025. All Rights Reserved by MedPath